High-coverage DNA sequence and modification profiling of targeted genomic elements using Nanopore-based Cas12a Targeted Ligation and Enrichment Sequencing (nCasTLES).

Imagine trying to read a specific sentence in a library containing billions of books, but the only way to read is to scan every single page of every single book. This is the fundamental challenge facing scientists who use a powerful new type of DNA sequencing technology called nanopore sequencing. This method is unique because it can read long strands of DNA in one go and, crucially, it can see chemical tags on the DNA that act like switches, turning genes on or off. These tags are vital for understanding diseases like cancer, but the technology has a major flaw: it is slow and inefficient. To find the specific genetic regions a scientist cares about, current methods often leave behind vast amounts of useless, "inert" DNA that clogs the machine, wasting time and money while preventing the researcher from reading other important information in the same sample.

A team of researchers at the University of Massachusetts Chan Medical School has developed a new way to solve this problem, allowing scientists to isolate exactly the DNA they want to study while keeping the rest of the sample clean and useful. They call their method nCasTLES. Instead of leaving the unwanted DNA to sit in the machine, this new approach physically removes it before sequencing begins. By using a molecular tool that acts like a pair of scissors to cut DNA at precise spots, the team creates tiny, sticky ends on the target DNA. They then use a magnetic-like capture system to pull only those specific pieces out of the mix, washing away the rest. This leaves a pure sample of the target DNA that can be sequenced alongside other DNA from the same sample, effectively doubling the value of the experiment.

The researchers tested this method on a complex genetic driver found in a specific type of cancer cell line. These cells contain extra rings of DNA, known as extrachromosomal DNA, which carry a high number of copies of a dangerous cancer gene called MYCN. Using their new technique, the team was able to isolate these specific DNA rings from the rest of the cell's genetic material. The results were striking: the new method captured nearly forty times more of the target DNA per hour compared to standard sequencing without enrichment. More importantly, because they removed the useless DNA, the machine ran longer and healthier, producing a massive amount of useful data. In a standard run, the machine might struggle to read anything else once the target DNA is found, but here, the researchers could also read the entire genome of the cancer cells in the same run, revealing the structure of those extra DNA rings with high precision.

To prove the method works on a more subtle level, the team turned to a gene called MGMT, which is often silenced by chemical tags in patients with a deadly brain tumor called glioblastoma. The ability to see these tags without destroying the DNA is a major advantage, as traditional methods require harsh chemicals that erase this information. The researchers mixed DNA from two different brain tumor cell lines: one where the gene was heavily tagged and silenced, and another where it was not. They used their new method to pull out the gene from both lines and sequence them together. The machine successfully distinguished the two cell lines based on tiny genetic differences and mapped the chemical tags on every single strand of DNA. This revealed that while the gene was generally silenced in one line, there were subtle differences in how the tags were arranged compared to the other line. The method even spotted rare strands that appeared to be in the middle of changing their tag status, a detail that would have been missed by older, shorter-read technologies.

The power of this approach extends beyond just finding known genes. The researchers also used it to track where a virus had inserted itself into the human genome, a process that happens randomly and is often used to study how cells behave. They infected cells with a lentivirus and then used their method to fish out the exact spots where the virus had landed. Because the method removes the rest of the DNA, they could see the virus's integration site and the surrounding human DNA in one piece. This allowed them to compare different groups of cells and see that some had the virus land in active parts of the genome, while others had it land in quiet, inactive areas. They found that cells with the virus in active areas grew faster and were more resistant to a chemotherapy drug, suggesting that the location of the insertion directly influenced the cell's behavior.

Perhaps the most surprising aspect of this work is what happened to the DNA that was washed away. In previous methods, the DNA that was not the target was discarded or rendered useless. In this new system, because the unwanted DNA is removed cleanly rather than just ignored, it can be saved and sequenced alongside the target. The researchers showed that this "waste" DNA could be used to build a complete map of the cancer cell's genome, revealing large-scale changes, such as the loss of an entire chromosome, that occurred as the cells grew. This means a single experiment can now answer multiple questions: it can look at a specific gene, see its chemical tags, track where a virus landed, and map the entire genome's structure all at once.

The study demonstrates that by changing how we prepare DNA for sequencing, we can get much more information from the same amount of material. The new method does not require massive amounts of starting DNA, which is often a limitation when working with precious patient samples. It also avoids the need for amplifying the DNA, a step that can introduce errors and erase the chemical tags scientists are trying to study. While the method has some limits, such as a maximum size for the DNA fragments it can handle, it represents a significant step forward in making third-generation sequencing practical for complex biological questions. By turning a process that was once a bottleneck into a streamlined workflow, this approach opens the door to studying the genome in ways that were previously too slow, too expensive, or too messy to attempt.